Literature DB >> 20195159

Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy.

Samuel N Heyman1, Seymour Rosen, Mogher Khamaisi, Jean-Marc Idée, Christian Rosenberger.   

Abstract

Experimental findings in vitro and in vivo illustrate enhanced hypoxia and the formation of reactive oxygen species (ROS) within the kidney following the administration of iodinated contrast media, which may play a role in the development of contrast media-induced nephropathy. Clinical studies indeed support this possibility, suggesting a protective effect of ROS scavenging or reduced ROS formation with the administration of N-acetyl cysteine and bicarbonate infusion, respectively. Furthermore, most risk factors, predisposing to contrast-induced nephropathy are prone to enhanced renal parenchymal hypoxia and ROS formation. In this review, the association of renal hypoxia and ROS-mediated injury is outlined. Generated during contrast-induced renal parenchymal hypoxia, ROS may exert direct tubular and vascular endothelial injury and might further intensify renal parenchymal hypoxia by virtue of endothelial dysfunction and dysregulation of tubular transport. Preventive strategies conceivably should include inhibition of ROS generation or ROS scavenging.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20195159     DOI: 10.1097/RLI.0b013e3181d2eed8

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  92 in total

Review 1.  Renal-related adverse effects of intravenous contrast media in computed tomography.

Authors:  Kheng Song Leow; Yi Wei Wu; Cher Heng Tan
Journal:  Singapore Med J       Date:  2015-04       Impact factor: 1.858

2.  Effect of low-osmolar contrast medium iopromide and iso-osmolar iodixanol on DNA fragmentation in renal tubular cell culture.

Authors:  Ulla Ludwig; Julia Connemann; Frieder Keller
Journal:  Clin Exp Nephrol       Date:  2013-01-24       Impact factor: 2.801

3.  Randomized Trial of Bicarbonate or Saline Study for the Prevention of Contrast-Induced Nephropathy in Patients with CKD.

Authors:  Richard Solomon; Paul Gordon; Steven V Manoukian; J Dawn Abbott; Dean J Kereiakes; Allen Jeremias; Michael Kim; Harold L Dauerman
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-16       Impact factor: 8.237

Review 4.  Measures used to treat contrast-induced nephropathy: overview of reviews.

Authors:  C S Kwok; C L Pang; J K Yeong; Y K Loke
Journal:  Br J Radiol       Date:  2013-01       Impact factor: 3.039

5.  In vivo nephroprotective efficacy of propolis against contrast-induced nephropathy.

Authors:  Murat Baykara; Sibel Silici; Mehtap Özçelik; Osman Güler; Nuri Erdoğan; Mehmet Bilgen
Journal:  Diagn Interv Radiol       Date:  2015 Jul-Aug       Impact factor: 2.630

6.  Iodinated contrast media cause direct tubular cell damage, leading to oxidative stress, low nitric oxide, and impairment of tubuloglomerular feedback.

Authors:  Zhi Zhao Liu; Kristin Schmerbach; Yuan Lu; Andrea Perlewitz; Tatiana Nikitina; Kathleen Cantow; Erdmann Seeliger; Pontus B Persson; Andreas Patzak; Ruisheng Liu; Mauricio M Sendeski
Journal:  Am J Physiol Renal Physiol       Date:  2014-01-15

7.  Pyridoxamine reduces postinjury fibrosis and improves functional recovery after acute kidney injury.

Authors:  Nataliya I Skrypnyk; Paul Voziyan; Haichun Yang; Christian R de Caestecker; Marie-Claude Theberge; Mathieu Drouin; Billy Hudson; Raymond C Harris; Mark P de Caestecker
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-18

8.  Non-ionic contrast media induces oxidative stress and apoptosis through Ca²⁺ influx in human neutrophils.

Authors:  Mustafa Kayan; Mustafa Nazıroğlu; Ishak Suat Ovey; Mehmet Aykur; Abdülhadi Cihangir Uğuz; Vedat Ali Yürekli
Journal:  J Membr Biol       Date:  2012-08-18       Impact factor: 1.843

9.  Heme oxygenase-1 counteracts contrast media-induced endothelial cell dysfunction.

Authors:  Chao-Fu Chang; Xiao-Ming Liu; Kelly J Peyton; William Durante
Journal:  Biochem Pharmacol       Date:  2013-11-15       Impact factor: 5.858

10.  Lessons learned from the PRESERVE trial.

Authors:  Sasan Partovi; Thomas Trischman; Preet S Kang
Journal:  Br J Radiol       Date:  2018-06-05       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.